Rapid Paediatric and Adolescent Anti-retroviral Therapy Optimization in Uganda, 2020-2021: a National Implementation Success During a Raging Covid19 Pandemic

Author:

Namusoke-Magongo Eleanor1,Nakanwagi Miriam1,Adoa Dennis2,Nyamitoro Ian1,Arinaitwe Ivan1,Nazziwa Esther3,Nkolo Esther Karamagi4,Nabitaka Vennie2,Chimulwa Teddy1,Kiranda Edward Katto1,Ayitewala Alisen5,Ochora Esther Nyamugisa6,Katureebe Cordelia1,Musinguzi Joshua1

Affiliation:

1. Ministry of Health

2. Clinton Health Access Initiative

3. Centers for Disease Control and Prevention

4. United States Agency for International Development (USAID)

5. Uganda National Health Laboratory Services

6. United Nations Children’s Fund

Abstract

Abstract Introduction Children and adolescents (0-19 years) living with HIV (CALHIV) in Uganda have historically had lower viral load suppression (VLS) rates than adults and this was partly attributed to sub-optimal antiretroviral therapy (ART) regimens. By June 2019, less than 50% of CALHIV were on optimal regimens despite appropriate policies in place. In July 2019, Ministry of Health (MOH) embarked on an ART optimization campaign to put all CALHIV on optimal regimens. We describe the process, challenges, and achievements during June 2019 – March 2021. Methods The campaign started in July 2019 and ART optimization was phased by age and by region due to ART stock shortage and gradually spread to the entire country with realization of sufficient stock. ART optimization referred to initiating or transitioning CALHIV on either an integrase strand transfer inhibitor(dolutegravir) or a protease inhibitor (Boosted lopinavir) as the anchor drug. Implementation of the campaign involved building capacity for ART optimization for all stakeholders and weekly use of robust data to monitor progress and make timely interventions along with regular supervision and onsite mentorships. MOH developed indicators on optimization which the implementing partners reported at weekly meetings facilitated by the MOH. A data call was made at end of March 2021 to determine the progress on ART optimization of CALHIV in Uganda and VLS analysis was done to assess the early impact of ART optimization. Results Adolescents comprised the majority (40,931/ 64,723; 63.2%) of CALHIV in HIV care by March 2021. Almost all (63,053/64,723; 97.4%) of CALHIV had been transitioned to optimal ART regimens. Despite the successful ART optimization for CALHIV, viral load suppression increased just slightly and remained suboptimal (<95%) by March 2021. Conclusions Proper preparation and timely data use for decision making enabled Uganda to succeed at ART optimization for almost all CALHIV amidst the COVID19 pandemic. However, ART optimization alone was not sufficient to have optimal viral load suppression nationally.

Publisher

Research Square Platform LLC

Reference25 articles.

1. National HIV estimates file | UNAIDS. Accessed March 31. 2021. https://www.unaids.org/en/dataanalysis/datatools/spectrum-epp.

2. PRESIDENTIAL FAST-TRACK INITIATIVE ON ENDING HIV AND AIDS IN UGANDA FACT SHEET 2019. Accessed March 31, 2021. https://www.uac.go.ug.

3. HIV Country Profile: 2016.

4. Uganda AIDS, Commission. HIV AND AIDS BURDEN.

5. Ministry of Health Uganda, ICAP. Uganda Population-Based Hiv Impact Assessment.; 2016. http://www.afro.who.int/sites/default/files/2017-08/UPHIA Uganda factsheet.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3